Although several genes causing familial cancer syndromes have been identified, susceptibility to sporadic cancer remains unsolved. Animal experiments have demonstrated a large number of quantitative trait loci affecting cancer susceptibility. Previously, we described in mouse strain CcS-19/Dem five susceptibility to colon cancer (Scc) loci, Scc1-Scc5 controlling tumor numbers. In the present study, we performed an independent identical mouse cross using a distinct carcinogen, azoxymethane, to induce colon tumors. We confirmed all five originally described Scc loci and detected five additional new Scc loci; Scc11-Scc15. All these loci were detected in two-way interactions.
Colorectal cancer is the third leading cause of cancer in Europe and US. Familial colon cancer explains only a small percentage of all colorectal cancer cases. The majority of cases is represented by sporadic cancer without any obvious genetic linkage. This, however, does not mean that there is no hereditary determinant of susceptibility. Genetic predisposition to nonfamilial, sporadic cancer is a major factor in cancer susceptibility (Lichtenstein et al., 2000) . Cancer susceptibility is controlled by many genes, acting either alone or through interactions with other genes. Nevertheless, the relevant genes do not have a strong effect and hence are difficult to detect (Ponder, 2001) . Therefore, mouse models are helping to understand cancer as a complex genetic trait. Inbred strains of mice differ widely in their susceptibility to both spontaneous and chemically induced tumors, and have been used to map several susceptibility quantitative trait loci (QTLs) and their mutual interactions (Balmain, 2002; Mao and Balmain, 2003) .
To study QTLs influencing the development of colon tumors, we have used the CcS/Dem series of recombinant congenic (RC) strains, derived from the mouse inbred strains BALB/cHeA (BALB/c) and STS/A (STS). BALB/c is resistant to chemically induced colon adenomas, whereas STS is susceptible. Each individual CcS strain contains a different random subset of approximately 12.5% of genes derived from the susceptible strain STS and 87.5% of genes from the resistant strain BALB/c. In this way, the STS alleles of different loci are divided between 20 different CcS strains, reducing the genetic complexity (Demant, 1992) .
Treatment of BALB/c and CcS-strain mice with repeated injections of the carcinogen 1,2-dimethylhydrazine (DMH) induces multiple colonic adenomas, that are benign, even if they are very large (Moen et al., 1991) . Five loci affecting susceptibility to chemically induced colon cancer, Scc1-Scc5, were previously identified using 192 F 2 mice between susceptible RC strain CcS-19 and BALB/c. A strong candidate gene for Scc1 was identified recently as Ptprj (protein tyrosine phosphatase receptor type-J). The demonstration that its human homolog PTPRJ is involved in several cancer types opens a possibility to identify the cancer susceptibility genes in animals and subsequently in humans (Ruivenkamp et al., 2002) .
In contrast to our previous studies using the carcinogen DMH alone or in combination with N-ethyl-Nnitrosourea (ENU) to induce colon tumors (Moen et al., 1992; Van Wezel et al., 1996) , we used the direct metabolite of DMH, the carcinogen azoxymethan (AOM). Pilot studies using AOM showed the same difference in colon tumor susceptibility between the two parental strains, BALB/c and STS, and the RC strain CcS-19 as reported previously for DMH-induced tumors (Moen et al., 1992; Van Wezel et al., 1996) . The number and size of the AOM-induced colon tumors, however, was markedly higher. In addition, we analysed the novel mouse cross with a more powerful statistical package that simultaneously assay possible main effects and pairwise interactions of microsatellite markers from all segregating segments (see legend to Table 1 ). The P-values given below for the novel loci and interactions indicate whole genome significance levels.
Analysis of 314 AOM-treated (BALB/c Â CcS-19)F 2 mice for the genetics of colon tumor number confirmed the five previously reported Scc loci and detected five new Scc loci, Scc11-Scc15 (Table 1) . The five novel loci were all detected in pairwise interactions, in which the effect of one locus depends on the genotype of the interacting locus (Tables 1 and 2 ). The novel locus Scc11 on chromosome 4 was detected in interaction with Scc3 (P ¼ 0.027) and gender (sex dependent; P ¼ 0.002). The locus Scc12 on chromosome 7 showed a significant and suggestive interaction with Scc5 (P ¼ 0.013) and Scc3 (P ¼ 0.10), respectively. We observed an interaction between two novel loci, the locus Scc13 on chromosome 6 and Scc14 on chromosome 10 (P ¼ 0.04). In addition, suggestive associations were shown for these two loci, Scc13 interacts with Scc1 (P ¼ 0.051), and Scc14 with Scc4 (P ¼ 0.167). Scc15 on chromosome 11 was found to interact with Scc5 (P ¼ 0.027).
We confirmed Scc1 and Scc2 on chromosome 2 as significant main effects. Importantly, the interaction between Scc4 and Scc5 was confirmed in the second Confirmation of Scc3. The genetic distribution of the RC strains used has been described peviously (http:// www.informatics.jax.org/searches/rcset forms.html). The mice were subjected to a strict light-dark regimen and received a standard laboratory diet (Hope Frams, Woerden, The Netherlands) ad libitum and tap water. F 2 crosses were generated between the background strain BALB/c and the RC strain CcS-19 at the National Institute of Public Health and Environment (RIVM) (Bilthoven, the Netherlands). Mice 12-18 weeks of age received 10 weekly subcutaneous injections of AOM (7.5 mg/kg bodyweight, diluted in saline). Mice were killed 29 weeks after the first injection, or earlier if the animals were moribund. At autopsy, the colon was removed, and the number of colon tumors was counted using a dissection microscope. DNA was prepared from mouse-tails using standard proteinase K procedure. The F 2 mice were genotyped with microsatellite markers as described previously (Mouse MapPairs TM, Research Genetics, Huntsville AL) (Van Wezel el al., 1996) . The chromosomal position of genes affecting colon tumor number in different chromosomal regions (with the use of individual microsatellite markers) was determined by analysis of variance. Normal distribution was obtained by square-root transformation of colon tumor number. The effect of each microsatellite marker, sex, and interactions between pairs (marker-marker and marker-sex) on tumor number was tested by the PROC GLM (general linear models) statement of the SAS s 6.12 for windows (SAS institute, Inc., Gary, NC, USA) (Tripodis et al., 2001) . Final P-values were corrected for multiple comparisons according to Lander and Kruglyak (1995) (Van Wezel et al., 1996); 4 Suggestive linkage Loci A and B are interacting (see Table 1 ); 2 effects in female mice; 3 effects in male mice. The data are presented as average number of colon tumors corrected for the effect of the remaining markers in the model (least-squares mean from SAS analysis of variance output). Only statistically significant linkage data are presented. The genotypes at locus A and locus B are CC for homozygotes for BALB/c allele, CS for heterozygotes, and SS for homozygotes for the STS allele. The Scc11 locus was detected as a main effect dependent on the sex of the mice cross, although less significant compared to the original cross (Van Wezel et al., 1996) . In addition, Scc5 has been found to interact with Scc1, 12, and 15. Differences in the effects of these loci between both F 2 crosses may be due to the absence or presence of additional interactions resulting from the different distribution of compound genotypes involving three or more loci in the two crosses. Scc3 is established in an interaction with Scc11, whereas originally it had been detected by its main effect. Similarly, we also detected novel two-way interactions for Scc1 and Scc4 (see above; Table 1 ).
In conclusion, this study describes the mapping of five novel loci involved in colon cancer susceptibility and their interactions. This result extends the number of Scc loci using the RC strain model to 15 (Van Wezel et al., 1996 , 1999 . The identification of a large number of cancer susceptibility loci and eventually candidate genes and their human homologs in combination with SNP genotyping and array technologies will help to reveal the presently unrecognized genetic and biological heterogeneity of (nonfamilial) cancers, with potential benefit for prevention and for individually optimized treatment strategies.
Abbreviations AOM, azoxymethane; Scc, susceptibility to colon cancer.
